Wednesday, July 1, 2009

No Gene is an Island


This is a saying I have been using for about 4 years now.
When someone asked about testing for HFE and why we don't do it as the first screening step anymore.....


They often looked at me confused.....I then bring up the case of sickle cell disease.

Most doctors have seen a sickle cell patient in the hospital.......They may have even seen a family in the hospital, brother and sister, Son and Mother......but what most don't know is that the majority of sicklers never go into the hospital.....


That's when I ask, what is the mutation that the son and mother have? The answer Sickle-cell anemia is caused by a point mutation in the β-globin chain of hemoglobin, causing the amino acid glutamic acid to be replaced with the hydrophobic amino acid valine at the sixth position.


Now what about the patients who never come into the hospital?


Sickle-cell anemia is caused by a point mutation in the β-globin chain of hemoglobin, causing the amino acid glutamic acid to be replaced with the hydrophobic amino acid valine at the sixth position.

Why is that? I answer my question as they have lots of guesses....

"No Gene is an Island"

You see, there are several things linked to the development of the adverse outcomes with sickle cell disease. Environment, Modifier Genes, Epigenetics (which ultimately is environment) I could go on from there........but suffice to say, genes can only provide us a small answer into the majority of diseases......

Drug metabolism, is a very different story at times.....


I then go on to say that there are very, very few diseases for which severity of disease or even disease itself is attributable to JUST one gene........ Or frankly to JUST ONE MUTATION..........

The body is a set of systems and by being super reductionist and looking at one gene or one mutation versus another, we ultimately end up missing the boat and making a big deal out of something which is not so big a deal......

Or we apply something which may be clinically valid but have little clinical utility.......

Even worse, we take something which has wonderful analytic validity and to use it clinically, with a huge waste of money and a huge waste of resources........
This is the case with DTC.

Some may argue that we should allow people to waste their money on anything they want. I tend to agree with this.

However, what should not be tolerated is false claims and manipulation of claims without scrutiny.

In addition, something which meets the definitions of medicine, should be held to that standard......plain and simple........
Taking human tissues/samples and using them for research requires an IRB, taking human tissues and using them to predict risk of disease IS MEDICINE..........and should be regulated as such......

There are a whole host of laws which regulate how a doctor can advertise, why are we not applying them to these companies who are performing such analysis?


But more importantly, why are these companies the only people educating the public. And doing a very slanted and manipulative job here......

No Gene is an Island......thus no SNP is the end all or be all of risk.....It is much more complex than that.

Which is why I say "Family History is the cheapest and most clinically useful Whole Genome analysis"


The Sherpa Says: Someone is watching these claims, I hope you come here to debunk their junk.

Tuesday, June 30, 2009

The Infer Game


What really gets me upset is that marketing people infer something but don't outright make a claim.

They do this because to make a claim which isn't true is grounds for the FTC to investigate you, but if you "infer" something, you don't make the claim....
Why do I jump on this?

Because I don't play "infer" for my patients.

In fact, health information and healthcare is too important to "infer" anything. You cannot manipulate peoples' trust in you....

Either we can justify via science and current medical practice or we cannot. Why let people dangle in the wind with false information.....


But this little game is nothing new. Vitamin hucksters and weight loss supplements play this "infer" game too.....so I guess the DTC genomics companies want to be seen as Hucksters....otherwise, why infer something which isn't true......


This went on with Navi's most recent blog post

It is possible that the Factor V mutation also confers a selective advantage to people who carry one copy, but scientists just aren’t sure yet.

If you carry the mutation, you can take steps to prevent becoming ill as a result. And, if you meet someone else who carries the mutation too, it’ll be a little like finding a long-lost brother or sister! Somewhere back in the human genetic family tree, the two of you have a “Factor V” ancestor in common.

The inferring that goes on is that there is some treatment that can prevent clots in these patients with Factor V Leiden. The truth is, there is no treatment to prevent these clots whose benefits outweigh the risks........

I already made this point with 23andMx's goofy CEO Anne Wojicki who made claims in a similar fashion on Charlie Rose the other night....

Pay attention closely, if the FTC doesn't jump in and investigate these companies' suspicious practices.........I will be surprised......very surprised....

Are you pissed at the inferring game too? Well, you too can voice a complaint to the FTC....

The Sherpa Says: DTC genomics companies are lucky that their product doesn't cause arrythmias, sudden death, liver failure or loss of smell.......But even if they don't their marketing claims certainly still do stink......

Monday, June 29, 2009

Great Job Mike! 2C19 meets the grade!


I was flipping through the internal medicine news yesterday when I saw a colleague. Mike Murray, Clinical Chief up at the Brigham who had given me some good advice re: being a fellow and academia......

He and a couple other internal medicine geneticists write a column called "Genetics in Your Practice"


Which is a welcome addition to what my wife and I (Both Internists) believe is one of the best print publications out there for keeping ahead of the curve with IM and subspecialties....

Well,

Mike wrote about Plavix, which, as you know, I have been all over since the studies came out in January showing significant differences in outcomes clinically with patients who cannot activate Plavix. Why was I all over it? Because it had met some criteria which I think will define what a good PGx test is......

I have as of yet failed to detail precisely what these criteria are.....It just so happens, Mike did a brilliant job of it.....So without further ado. Dr. Mike Murray, Internists, ID specialist AND geneticist defining the criteria....


From Internal Medicine News

So, what will bring a breakthrough application in pharmacogenetics? I believe that a true breakthrough into the mainstream will occur when the gene-drug pair has many or all of these characteristics:

▸ A widely used drug. There are currently some excellent examples of gene-drug pairs as models for the clinical application of pharmacogenetics; however, they happen to be with drugs used by only a small number of subspecialists. A true breakthrough application will need to be a widely used medication.

▸ An “essential” drug. Although we may eventually get to pharmacogenetics testing for almost all medications, a true breakthrough application will not be for a drug for which the application is usually elective (e.g., onychomycosis therapy) or for a drug that has equivalent substitutes inside or outside of the class (e.g., a diuretic for hypertension).

▸ Potentially severe consequences from use of the drug without pharmacogenetics guidance. The motivation for using a pharmacogenetics approach is mainly safety or efficacy. The breakthrough application will need to help the prescriber avoid morbidity or mortality associated with side effects or ineffective treatment.

▸ A narrow therapeutic window. Aminoglycoside antibiotics are classic examples of drugs with a narrow therapeutic window, where underdosing can lead to disease progression and overdosing can cause adverse effects.

▸ Pharmacoeconomic advantage. The application of new technology to guide gene-drug decision making will be more attractive for clinical uptake in instances where it offers cost savings.

▸ Straightforward genetic interpretation. Much of current genetic testing deals with complex interpretations of sequence data where variants unique to the individual patient have to be judged as causative, noncausative, or of unknown significance. In 2009 the most straightforward diagnostic genetic testing is based on screening for common variants that confer increased relative risk.

▸ Validated significance of gene-drug pair. There will always be varied levels of confidence in any data set; however, replication of significant correlation in more than one large, well-designed study will be the most likely to be associated with rapid clinical uptake.

This is precisely what Plavix is......And it is precisely why it will lead personalized medicine this year.......Not genome scans, not whole genomes, Plavix pharmacogenomics...... Mike, yet again, you have crystallized criteria which I often find nebulous......

The Sherpa Says: If we judge all tests by this criteria we would be better off.......Imagine how many less tests would be ordered. Bad for business, great for medicine......

Thursday, June 25, 2009

23andMx looking to cook the books in CA with SB 482


Daniel MacArthur and I have been noticing something and he decided to cover it today, which is why I have decided to provide a counterpoint here....Also GenomeWeb published on this. SB 482 is a bill I glossed over in a post in the past and was recently interviewed for in the San Jose Mercury News.......

Daniel leads this as 23andMx leading the regulatory push.....but this is more insidious than that. This is 23andMx trying to cook the books and create laws which exempt them from the stringent regulation which they should receive......

I told this to the newsies over at San Jose on Sunday, so I am going to post this today......

It turns out that this bill SB 482 essentially exempts DTC companies from facing the harshest regulations that medical providers/labs have to face


From Daniel
"In other words, 23andMe is pushing to have companies purely providing analysis of genetic data regulated separately from those doing the actual laboratory testing. Since 23andMe out-sources its testing to an external laboratory, this would exempt the company from some regulatory requirements. The move follows some fairly serious regulatory controversy over direct-to-consumer testing in California a year ago."

Which I predicted BTW....... But in all seriousness, these portals to lab services view themselves as NON MEDICAL entities, that is the crux of this argument, and by passing this bill it would set legal precedent as being non-medical and not facing medical regulations......

But that bill should fall flat. Why? Because it is written with a false logic. I am about to explain the correct logic............

The assumption is, that by only running an algorithm on biodata and giving a risk number, you are not practicing medicine.....nor is it running a laboratory....

Thus they don't need healthcare
regulation or medical lab regulations.....but they are dead wrong.....

The first myth: Running an algorithm on biodata and giving a risk estimate is not medicine.......

Answer: IN FACT it IS medicine, the AMA guide book for Current Procedural Terminology acknowledges that this IS medicine and it should be coded with the number
99420 of the evaluation and management code..... I run something called a reynolds risk calculation on patients. It is a computer algorithm found at www.reynoldsriskscore.com. Give it a shot, you will see it is very similar to a DTC genomic test. I bill and get paid for providing this medical service......

The Second Myth: Because we don't run the test, we shouldn't be responsible for CLIA regulations. We are not a laboratory.....

Answer: This company actually accepts ownership for the sample and provides specimen handling which is delivered to an analytical facility.....By merely handling the specimen they need to be considered as part of the healthcare unit, or apply for CLIA exemption. Any handling of any specimen can be billed for and should be regulated as such..... Not the shipper, the company/person/lab who takes ownership of the specimen.....

Lastly,

I was on twitter last night when I saw this ugly retweet come from the account at 23andMx
RT @dane: @23andMe BTW, you saved me $25 for a CF test - used my and spouse's 23 results instead. Thx! (via @23andMe)

Which raised eyebrows from myself and Daniel

"@23andMe For once I agree with (Steve) - implicitly promoting your chip as replacement for a validated CF test is a risky move.I basically said that this is the type of shennanigans coming from a company who isn't being regulated.

If they were, this insinuation that using a 23andMx test for a clinical use, would never bubble up.....but it did.

And I am willing to bet the twitterer for 23andMx isn't medical at all.......
Which is once again why, oh why SB 482 needs to be shot down immediately....

I am glad the ACLU is on this, but the AMA, The ACMG and the NSGC need to be all over this bill too........

As you can see from the edits, this bill was initially proposed as a healing arts bill, which is what it is....... But even with that, 23andMx has no use for YOUR laws.......

The Sherpa Says: 23andMx deleted that tweet, so at least they understand that what they are doing WAS and still is wrong......

Tuesday, June 23, 2009

Anne Wojicki, First Benadryl doping, now Factor V


I was actually watching the Charlie Rose interview with the 23andMx ladies....When Charlie Asks what the advantage of 23andMx is.

Anne and Linda both say
"The problem with the GWAS is that you aren't followed over time. You get one shot and people can't give you further information"

What Anne and Linda are saying is: The Coriell Personalized Medicine Collaborative is the gold standard, we are merely trying to monetize something they are doing for FREE.


In addition, we are not IRB approved and are unethically doing this business, which is ultimately research. Which IS being done by a Not For Profit Medical Institution, Who is charging nothing I.E. FREE, and we would like to do what they are, but charge you 399 and have the right to sell your data......

Oh and did we mention that Google just put another 2.6 million into our bank accounts?????


But probably the funniest thing Anne had to say was at
minute 18 of the clip on the PGP site..... Anne says "It's early, but there is a lot of interesting and valuable data in there (the genome scan)"

She then goes on to say
"For Instance, there is a genetic marker for Blood Clots called Factor Five Leiden. Charlie, I am certain you must travel a lot. Wouldn't you like to know if you were at risk for these clots?"

That is when it hit me, for the 3000th time.

A.Neither of these ladies is in medicine
B. Neither of these ladies are PhD scientists
C. Neither of these ladies understand what it really means to be carrying out this type of study.

Hence

1. NO IRB
2. Promoting Factor V Leiden testing despite evidence to the contrary and a HUGE AHRQ report
3. Doping up their kid for transcontinental flights with benadryl!
4. She even said you might want to take medications for Factor V Leiden!
OMG!

Why is the world listening to these silly ladies????

Why aren't they listening to themselves?

They both plainly stated, Coriell is the best study and that they want to be Coriell, without ever mentioning the name Coriell.

But the best line in the ENTIRE interview came when she said "With budgets these days, you may or may not end up flying economy class these days........." Charlie quips "WHEN WAS THE LAST TIME YOU FLEW BUSINESS CLASS?"

The Sherpa Says: There you have it, 23andMx's leadership endorsing Coriell's study. For FREE, not 399 USD. Oh and with an IRB and without Google.......

Watch Out Corporate Bloggers, FTC is on to you!


Now not only am I bashing corporate bloggers (Some may even call me corporate) Now the Federal Trade Commission has gotten into the game. It turns out that the FTC is on to the game of freebies for good blogging.

So to all of you who took free Navi or 23andMx or DeCodeme scans in hopes of them getting good press on your blog, you may have some issues. At least if you are in the US.....


From the Yahoo News

What some fail to realize, though, is that such reviews can be tainted: Many bloggers have accepted perks such as free laptops, trips to Europe, $500 gift cards or even thousands of dollars for a 200-word post. Bloggers vary in how they disclose such freebies, if they do so at all.

The practice has grown to the degree that the Federal Trade Commission is paying attention. New guidelines, expected to be approved late this summer with possible modifications, would clarify that the agency can go after bloggers — as well as the companies that compensate them — for any false claims or failure to disclose conflicts of interest.

So what does this mean for the genomics blogging world? A ton. I remember many, I mean many bloggers getting free kits. I also remember many people writing glowing reviews. I also know that the corporate blogs have been "inferring" things about what a genome scan can and cannot do........

The Sherpa Says: Just another case of government coming in and regulating for the protection of its citizens. Because of their commoners inability to sift through bull$h!t and hype. Time will tell what these new powers will do to the blogging community. I wonder what it will do for Twitter??? Wouldn't the government save a lot of money if they just made marketing illegal?

Monday, June 22, 2009

Crazy Friday, Awesome Call, Tru Blocks the Sherpa


I was amazed the first time I met Francis Collins, longtime a hero of mine, Francis was gracious and kind when I met him. I also share a common bond with him. Francis' Intern at UNC was a guy by the name of Jim Sabetta, one of my instructors....


That being said, before I started HH, I watched webcast after webcast of the SACGHS. This was 2005 and 2006 I'm talking about. I did it because it was research. But I saw a guy on there who inspired me, who had such a sense of reason that the whole group respected. His name is Muin Khoury.....and I just met him Friday!

It turns out we also have people in common. But more importantly, we have a healthy respect for family history in common...... This guy and his team at the CDC have been researching Family History tools and the state of the science of family history pretty aggressively. This team is a heavyweight in the field and I am blown away by what they are doing.

Why?

It is the cheapest whole genome, phenome, metabolome scan we have today. The best part is that it covers multiple people with just one take!


They are actually researching the role effect of family history on behaviors and diseases! Something which NEEDS to be done, just like it does for SNP sandcans. Except of course, Family History costs nothing.....and has some good data already! Their FamilyHealthware methods have just been released!
I will cover this further in depth in another post....

I am a little ad that I didn't get invited to GAPPnet, but am very excited to see what this conference in August on the state of the science in family history will bring.....More on this later



"Update" of TruGenetics.

While I WAS optimistic that a physician was at the helm of this company, I was reminded once again that we can be shady as well. It turns out, Dan Vorhaus AKA Genomicslawyer, read the fine print of the consent form. HT Daniel MacArthur too! It turns out Free is not so Free. Its now out that if you consent, you give the green light to TruGenetics sharing your results with companies and that your data goes into a database for "research" OK, that's strike one and strike 2......


The high heater came when I was following the COO of TruGenetics on Twitter......I challenged some of thet things he had said, like I do @Lindaavey @23andMx @Navi......But unlike those companies that stand up and defend themselves and agree to spirited debate with me.......@Achamedian the COO of TruGenetics "blocked" me!

Strike three TruGenetics.

You are out! I am deeply disappointed that you wouldn't debate me. It shows your TRU-Colors, to run and hide and also hide the fact that you are taking people's DNA for compensation of about 299 USD......
Not impressive. Nor is your call rate and error rate of 5%...... I guess you get what you pay for, when of course that product isn't hyped by large PR firms...


The Sherpa Says: Don't sign up for TruGenetics and if you do, at least you now know that they have a shady COO who runs from the questions and from the Sherpa!